Longitudinal changes in maternal corin and mid‐regional proatrial natriuretic peptide in women at risk of pre‐eclampsia

Corin, an atrial natriuretic peptide‐converting enzyme, has been found to promote trophoblast invasion and spiral artery remodeling. Yet, elevated maternal plasma atrial natriuretic peptide (ANP) and corin levels have been reported in pregnancies complicated by pre‐eclampsia (PE). The aim of this study was to investigate longitudinal changes in maternal plasma levels of corin and mid‐regional proatrial natriuretic peptide (MR‐PANP) in pregnancies that develop PE and gestational hypertension (GH).

[1]  K. Nicolaides,et al.  Longitudinal changes in maternal hemodynamics in a population at risk for pre‐eclampsia , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[2]  H. Zeisler,et al.  Augmentation index and pulse wave velocity in normotensive and pre‐eclamptic pregnancies , 2013, Acta obstetricia et gynecologica Scandinavica.

[3]  G. Badger,et al.  Prepregnancy Vascular Dysfunction in Women who Subsequently Develop Hypertension During Pregnancy. , 2013, Pregnancy hypertension.

[4]  K. Nicolaides,et al.  Maternal racial origin and adverse pregnancy outcome: a cohort study , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[5]  Q. Wu,et al.  Role of corin and atrial natriuretic peptide in preeclampsia. , 2013, Placenta.

[6]  Jingjing Jiang,et al.  Salt-Sensitive Hypertension and Cardiac Hypertrophy in Transgenic Mice Expressing a Corin Variant Identified in Blacks , 2012, HYPERTENSION.

[7]  T. Clutton-Brock,et al.  Saving Mothers’ Lives: Reviewing Maternal Deaths to Make Motherhood Safer 2006-2008 A Review , 2012 .

[8]  K. Nicolaides,et al.  Maternal hemodynamics at 11–13 weeks' gestation and risk of pre‐eclampsia , 2012, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  W. Cheng,et al.  Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy , 2012, Nature.

[10]  R. Dechend,et al.  Cardiovascular Biomarker Midregional Proatrial Natriuretic Peptide During and After Preeclamptic Pregnancies , 2012, Hypertension.

[11]  Robert J Doonan,et al.  The association between preeclampsia and arterial stiffness , 2012, Journal of hypertension.

[12]  M. Sinha,et al.  Effects of Progesterone Treatment on Expression of Genes Involved in Uterine Quiescence , 2011, Reproductive Sciences.

[13]  V. Bolshakov,et al.  ES cell-derived renewable and functional midbrain dopaminergic progenitors , 2011, Proceedings of the National Academy of Sciences.

[14]  K. Nicolaides,et al.  Maternal Arterial Stiffness in Women Who Subsequently Develop Pre-Eclampsia , 2011, PloS one.

[15]  M. Paech,et al.  Faculty Opinions recommendation of Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. , 2011 .

[16]  A. Houng,et al.  Decompensated Heart Failure Is Associated With Reduced Corin Levels and Decreased Cleavage of Pro–Atrial Natriuretic Peptide , 2011, Circulation. Heart failure.

[17]  J. Neilson,et al.  Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008 , 2011, BJOG : an international journal of obstetrics and gynaecology.

[18]  Argyro Syngelaki,et al.  Prediction of early, intermediate and late pre‐eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks , 2011, Prenatal diagnosis.

[19]  S. Gambaryan,et al.  Decreased renal corin expression contributes to sodium retention in proteinuric kidney diseases. , 2010, Kidney international.

[20]  L. Kappos,et al.  Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke. , 2010, Journal of the American College of Cardiology.

[21]  K. Spencer,et al.  First‐trimester markers for the prediction of pre‐eclampsia in women with a‐priori high risk , 2010, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[22]  P. Ponikowski,et al.  Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. , 2010, Journal of the American College of Cardiology.

[23]  P. Liu,et al.  Plasma Soluble Corin in Patients With Heart Failure , 2010, Circulation. Heart failure.

[24]  A. Hafezi-Moghadam,et al.  Atrial natriuretic peptide reduces vascular leakage and choroidal neovascularization. , 2009, The American journal of pathology.

[25]  A. Larsson,et al.  Assessment of left ventricular structure and function in preeclampsia by echocardiography and cardiovascular biomarkers , 2009, Journal of hypertension.

[26]  K. Nakao,et al.  Impaired Recovery of Blood Flow After Hind-Limb Ischemia in Mice Lacking Guanylyl Cyclase-A, a Receptor for Atrial and Brain Natriuretic Peptides , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[27]  T. Wieland,et al.  The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. , 2009, The Journal of clinical investigation.

[28]  Lelia Duley,et al.  The global impact of pre-eclampsia and eclampsia. , 2009, Seminars in perinatology.

[29]  I. Kullo,et al.  Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. , 2009, American Journal of Hypertension.

[30]  Y. O. Xu-Cai,et al.  Corin: new insights into the natriuretic peptide system. , 2009, Kidney international.

[31]  A. Khalil,et al.  Pulse wave analysis: a preliminary study of a novel technique for the prediction of pre‐eclampsia , 2009, BJOG : an international journal of obstetrics and gynaecology.

[32]  H. Cohen.  Who is salt-sensitive? , 2008, American journal of hypertension.

[33]  K. Blakemore,et al.  Atrial natriuretic peptide production and natriuretic peptide receptors in the human uterus and their effect on myometrial relaxation. , 2008, American journal of obstetrics and gynecology.

[34]  J. Qin,et al.  Corin Variant Associated With Hypertension and Cardiac Hypertrophy Exhibits Impaired Zymogen Activation and Natriuretic Peptide Processing Activity , 2008, Circulation research.

[35]  L. Vatten,et al.  Prepregnancy cardiovascular risk factors as predictors of pre-eclampsia: population based cohort study , 2007, BMJ : British Medical Journal.

[36]  A. Hingorani,et al.  Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis , 2007, BMJ : British Medical Journal.

[37]  J. Takahashi,et al.  Differences in neurogenic potential in floor plate cells along an anteroposterior location: midbrain dopaminergic neurons originate from mesencephalic floor plate cells , 2007, Development.

[38]  T. Kööbi,et al.  Natriuretic peptides and hemodynamics in preeclampsia. , 2007, American journal of obstetrics and gynecology.

[39]  M. Schull,et al.  Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study , 2005, The Lancet.

[40]  M. Drazner,et al.  Corin Gene Minor Allele Defined by 2 Missense Mutations Is Common in Blacks and Associated With High Blood Pressure and Hypertension , 2005, Circulation.

[41]  J. Spencer-Jones,et al.  Make every mother and child count. , 2005, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[42]  W. Dole,et al.  Hypertension in mice lacking the proatrial natriuretic peptide convertase corin. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  O. Vuolteenaho,et al.  Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. , 2004, Clinical chemistry.

[44]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[45]  R. T. Lie,et al.  Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. , 2001, BMJ : British Medical Journal.

[46]  J. Granger,et al.  Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. , 2001, Hypertension.

[47]  J. Pell,et al.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129 290 births , 2001, The Lancet.

[48]  Jean-Marie Moutquin,et al.  The Classification and Diagnosis of the Hypertensive Disorders of Pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) , 2001, Hypertension in pregnancy.

[49]  B. Clarke,et al.  Localization of the mosaic transmembrane serine protease corin to heart myocytes. , 2000, European journal of biochemistry.

[50]  J. Morser,et al.  Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[51]  S. Boschi,et al.  Relationship of systemic hemodynamics, left ventricular structure and function, and plasma natriuretic peptide concentrations during pregnancy complicated by preeclampsia. , 2000, American journal of obstetrics and gynecology.

[52]  J. Morser,et al.  Corin, a Mosaic Transmembrane Serine Protease Encoded by a Novel cDNA from Human Heart* , 1999, The Journal of Biological Chemistry.

[53]  E. Ringelstein,et al.  Peripartal Temporal Course of Endothelin 1, Angiotensin II, and Atrial Natriuretic Peptide in Pre-Eclampsia and Normotensive Pregnancy , 1998, Fetal Diagnosis and Therapy.

[54]  A. Hartikainen,et al.  Midtrimester N‐terminal Proatrial Natriuretic Peptide, Free Beta hCG, and Alpha‐fetoprotein in Predicting Preeclampsia , 1998, Obstetrics and gynecology.

[55]  P. Trindade,et al.  Mechanisms of natriuretic-peptide-induced growth inhibition of vascular smooth muscle cells. , 1997, Cardiovascular research.

[56]  A. Pouta,et al.  An Increase of the Plasma N‐terminal Peptide of Proatrial Natriuretic Peptide in Preeclampsia , 1997, Obstetrics and gynecology.

[57]  J. Tremblay,et al.  Characterization and distribution of natriuretic peptide receptors in the rat uterus. , 1995, Endocrinology.

[58]  O. Smithies,et al.  Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension , 1995, Science.

[59]  M. Miodovnik,et al.  Selective Vasodilator Effects of Atrial Natriuretic Peptide in the Human Placental Vasculature , 1995, The Journal of the Society for Gynecologic Investigation: JSGI.

[60]  N. Sjöberg,et al.  Atrial natriuretic peptide antagonizes the contractile effect of angiotensin II in the human uterine artery. , 1994, Human reproduction.

[61]  H. Itoh,et al.  Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy. , 1994, Biochemical and biophysical research communications.

[62]  James M. Roberts,et al.  Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.

[63]  L. Wartofsky,et al.  Atrial natriuretic peptide receptors in human endometrial stromal cells. , 1992, The Journal of clinical endocrinology and metabolism.

[64]  C. Grunewald,et al.  Atrial natriuretic peptide concentrations and hemodynamic effects of acute plasma volume expansion in normal pregnancy and preeclampsia , 1992, Obstetrics and gynecology.

[65]  H. Itoh,et al.  Atrial Natriuretic Polypeptide as a Novel Antigrowth Factor of Endothelial Cells , 1992, Hypertension.

[66]  C. Redman.  Pre-eclampsia and the placenta , 1991 .

[67]  H. Itoh,et al.  Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. , 1990, The Journal of clinical investigation.

[68]  C. Hatjis,et al.  Atrial natriuretic factor maternal and fetal concentrations in severe preeclampsia. , 1989, American journal of obstetrics and gynecology.

[69]  G. Thamsborg,et al.  Atrial natriuretic peptide concentrations in pre-eclampsia. , 1987, British medical journal.

[70]  J. Anderson.  Atrial natriuretic peptide concentrations in pre-eclampsia , 1987, British medical journal.

[71]  S. Bloom,et al.  The plasma release of atrial natriuretic peptide in man. , 1986, Clinical science.

[72]  R. Rodeheffer,et al.  Atrial pressure and secretion of atrial natriuretic factor into the human central circulation. , 1986, Journal of the American College of Cardiology.

[73]  M. Zaki,et al.  Plasma soluble corin and N-terminal pro-atrial natriuretic peptide levels in pregnancy induced hypertension. , 2012, Pregnancy hypertension.

[74]  J. Burnett,et al.  Corin is present in the normal human heart, kidney, and blood, with pro-B-type natriuretic peptide processing in the circulation. , 2011, Clinical chemistry.

[75]  J. Struck,et al.  Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma. , 2004, Clinical chemistry.

[76]  T. Flynn,et al.  Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[77]  P. Vaillancourt,et al.  Differential effects of rat pregnancy on uterine and lung atrial natriuretic factor receptors. , 1998, American journal of physiology. Endocrinology and metabolism.

[78]  D. Rizk.  A study of alpha-human atrial natriuretic peptide in normal pregnancy and in pre-eclampsia. , 1997, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.